Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novavax
Fierce Pharma
Novavax bets on ‘amplification strategy’ with Sanofi, Pfizer deals
Several other pharma companies have signed material transfer agreements so that they can experiment with Novavax's Matrix-M before committing to a deal.
Angus Liu
Apr 6, 2026 8:37am
Bayer radiology head takes top U.S. pharma spot—Chutes & Ladders
Apr 3, 2026 8:30am
Pfizer pens $530M deal to use Novavax adjuvant on 2 programs
Jan 20, 2026 10:40am
FDA puts Novavax's phase 3 plan on hold for pair of vaccines
Oct 16, 2024 9:10am
Acadia brings BMS vet on board as CEO—Chutes & Ladders
Sep 27, 2024 8:30am
Novavax's 2nd round of job cuts impacted 12% of staff
Jan 31, 2024 11:57am
